10 research outputs found
Linking Research to Educational Policy and Practice: What Kind of Relationships in How (de)Centralized a Context?
There have been debates on two issues related to the process of improving educational quality. The first concerns the alternative models for the relationship between researchers and policymakers/practitioners in efforts in efforts to link research and policy/practice. The second involves arguments about merits of centralized, linear versus decentralized, iterative strategies for reforming education. In this chapter, we summarize the issues raised in these debates and then explore them using illustrations drawn from documentation research of a USAID-funded project, Improving Educational Quality (IEQ), which operated in Ghana, Guatemala and Mali during the years from 1992 to 1996
Recommended from our members
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
Low dose aspirin therapy plays a fundamental role in both the primary and secondary prevention of cardiovascular events. Although the evidence using low dose aspirin for secondary prevention is well-established, the decision to use aspirin for primary prevention is based on an evaluation of the patient’s risk of cardiovascular events compared to their risk of adverse events, such as bleeding. In addition to the risk of bleeding associated with long term aspirin administration, upper gastrointestinal side effects, such as dyspepsia often lead to discontinuation of therapy, which places patients at an increased risk for cardiovascular events. One option to mitigate adverse events and increase adherence is the addition of esomeprazole to the medication regimen. This review article provides an evaluation of the literature on the concomitant use of aspirin and esomeprazole available through February 2013. The efficacy, safety, tolerability, cost effectiveness, and patient quality of life of this regimen is discussed. A summary of the pharmacokinetic and pharmacodynamic interactions between aspirin and esomeprazole, as well as other commonly used cardiovascular medications are also reviewed. The addition of esomeprazole to low dose aspirin therapy in patients at high risk of developing gastric ulcers for the prevention of cardiovascular disease, significantly reduced their risk of ulcer development. Pharmacokinetic and pharmacodynamic studies suggested that esomeprazole did not affect the pharmacokinetic parameters or the antiplatelet effects of aspirin. Therefore, for those patients who are at a high risk of developing a gastrointestinal ulcer, the benefit of adding esomeprazole likely outweighs the risks of longer term proton pump inhibitor use, and the combination can be recommended. Administering the two agents separately may also be more economical. On the other hand, for those patients at lower risk of developing a gastrointestinal ulcer, both the additional risk and cost make the inclusion of a proton pump inhibitor unwarranted
The Politics of Linking Educational Research, Policy, and Practice: The Case of Improving Educational Quality in Ghana, Guatemala and Mali
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
Stricturing and penetrating complications account for substantial morbidity and health-care costs in paediatric and adult onset Crohn’s disease. Validated models to predict risk for complications are not available, and the effect of treatment on risk is unknown